摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[2-(3,4-dimethoxyphenyl)ethyl]benzene-1,2-diamine | 5761-37-5

中文名称
——
中文别名
——
英文名称
N-[2-(3,4-dimethoxyphenyl)ethyl]benzene-1,2-diamine
英文别名
N-(3,4-Dimethoxy-phenylaethyl)-o-phenylendiamin;N-(3,4-Dimethoxy-phenaethyl)-o-phenylendiamin;N1-(3,4-dimethoxyphenethyl)benzene-1,2-diamine;2-N-[2-(3,4-dimethoxyphenyl)ethyl]benzene-1,2-diamine
N-[2-(3,4-dimethoxyphenyl)ethyl]benzene-1,2-diamine化学式
CAS
5761-37-5
化学式
C16H20N2O2
mdl
——
分子量
272.347
InChiKey
BKTXIZUTZYIZOD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    78 °C
  • 沸点:
    460.3±45.0 °C(Predicted)
  • 密度:
    1.152±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    20
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    56.5
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2922299090

SDS

SDS:91f68f64dcd79996de4931a680633a1c
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    四氧嘧啶N-[2-(3,4-dimethoxyphenyl)ethyl]benzene-1,2-diamine硼酸溶剂黄146 作用下, 以84%的产率得到10-(3,4-dimethoxyphenethyl)benzo[g]pteridine-2,4(3H,10H)-dione
    参考文献:
    名称:
    Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis
    摘要:
    This article describes discovery of a novel and new class of cholinesterase inhibitors as potential therapeutics for Alzheimer's disease. A series of novel isoalloxazine derivatives were synthesized and biologically evaluated for their potential inhibitory outcome for both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). These compounds exhibited high activity against both the enzymes AChE as well as BuChE. Of the synthesized compounds, the most potent isoalloxazine derivatives (7m and 7q) showed IC50 values of 4.72 mu M and 5.22 mu M respectively against AChE; and, 6.98 mu M and 5.29 mu M respectively against BuChE. These two compounds were further evaluated for their anti-aggregatory activity for beta-amyloid (A beta) in presence and absence of AChE by performing Thioflavin-T (ThT) assay and Congo red (CR) binding assay. In order to evaluate cytotoxic profile of these two potential compounds, cell viability assay of SH-SY5Y human neuroblastoma cells was performed. Further, to understand the binding behavior of these two compounds with AChE and BuChE enzymes, docking studies have been reported. (C) 2015 Elsevier Inc. All rights reserved.
    DOI:
    10.1016/j.bioorg.2015.05.005
  • 作为产物:
    参考文献:
    名称:
    Synthesen von Chinoxalin-Derivaten †
    摘要:
    Es werden在1-Stellung苄基和苯基thyyrlierte 3-Benzyl-1,2-dihydrochinoxalin-2-one,1,6,7-trisubituierte 1,2-Dihydrochinoxalin-2-one和-3-Methyldihydrochinoxalin-2-one,verätherte 2-羟基-喹喔啉,1,2,3,4-四氢喹喔啉和苯并四氢呋喃衍生物,药代动力学合成法。
    DOI:
    10.1002/hlca.19660490214
点击查看最新优质反应信息

文献信息

  • Synthesen von Chinoxalin-Derivaten
    作者:H. Zellner、G. Zellner
    DOI:10.1002/hlca.19660490214
    日期:1966.3.10
    Es werden in 1-Stellung benzylierte und phenyläthylierte 3-Benzyl-1,2-dihydrochinoxalin-2-one, 1,6,7-trisubstituierte 1,2-Dihydrochinoxalin-2-one und -3-Methyldihydrochinoxalin-2-one, verätherte 2-Hydroxy-chinoxaline, sowie 1,2,3,4-Tetrahydrochinoxaline und deren Quartärisate beschrieben, die zwecks pharmakologischer Prüfung synthetisiert wurden.
    Es werden在1-Stellung苄基和苯基thyyrlierte 3-Benzyl-1,2-dihydrochinoxalin-2-one,1,6,7-trisubituierte 1,2-Dihydrochinoxalin-2-one和-3-Methyldihydrochinoxalin-2-one,verätherte 2-羟基-喹喔啉,1,2,3,4-四氢喹喔啉和苯并四氢呋喃衍生物,药代动力学合成法。
  • A Practical Oxone®-Mediated,High-Throughput, Solution-Phase Synthesis of Benzimidazolesfrom 1,2-Phenylenediamines and Aldehydes and its Application toPreparative Scale Synthesis
    作者:Pierre Beaulieu、Bruno Haché、Elisabeth von Moos
    DOI:10.1055/s-2003-40888
    日期:2003.8
    Addition of oxone® to a mixture of a 1,2-phenylenediamine and an aldehyde in wet DMF at room temperature results in rapid formation of benzimidazoles under very mild conditions. The reaction is applicable to a wide range of substrates including aliphatic, aromatic and heteroaromatic aldehydes, and is not significantly affected by steric or electronic effects. In most cases, crude products are isolated in good to excellent yields (59-95%) and homogeneities (86-99%) by simple precipitation or extraction from the reaction mixture and do not require additional purification. Limitations to the scope of this methodology were encountered in cases where aldehydes were sensitive to oxone® under the acidic reaction conditions. The features of this methodology make it particularly well suited for the high-throughput, solution-phase synthesis of benzimidazole libraries. The low cost and simplicity of this procedure makes it equally attractive for preparative-scale syntheses where safety and environmental issues are of greater concern.
    在室温下,将oxone®添加到1,2-苯二胺和醛的湿DMF混合物中,可以在非常温和的条件下快速形成苯并咪唑。该反应适用于多种底物,包括脂肪族、芳香族和杂芳香族醛,并且不受立体或电子效应的显著影响。在大多数情况下,粗产物通过简单的沉淀或从反应混合物提取,得到了良好至优异的产率(59-95%)和均匀性(86-99%),且不需要额外的纯化。该方法的适用范围在某些对oxone®在酸性反应条件下敏感的醛的情况下受到限制。这种方法的特点使其特别适合于苯并咪唑库的高通量溶液相合成。该程序的低成本和简单性也使其在对安全和环境问题更为关注的制备规模合成中同样具有吸引力。
  • [EN] INHIBITORS OF HISTONE DEACETYLASE<br/>[FR] INHIBITEURS DE L'HISTONE DESACETYLASE
    申请人:METHYLGENE INC
    公开号:WO2006102760A1
    公开(公告)日:2006-10-05
    [EN] This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of formula (I); wherein Y, L, Z, W, X, Q, R1, R2 and R3 are as defined in the specification.
    [FR] L'invention concerne des composés inhibiteurs de l'histone-désacétylase. L'invention concerne en particulier des composés représentés par la formule (I) dans laquelle Y, L, Z, W, X, Q, R1, R2 et R3 sont tels que définis dans les spécifications.
  • Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis
    作者:Ashish M. Kanhed、Anshuman Sinha、Jatin Machhi、Ashutosh Tripathi、Zalak S. Parikh、Prakash P. Pillai、Rajani Giridhar、Mange Ram Yadav
    DOI:10.1016/j.bioorg.2015.05.005
    日期:2015.8
    This article describes discovery of a novel and new class of cholinesterase inhibitors as potential therapeutics for Alzheimer's disease. A series of novel isoalloxazine derivatives were synthesized and biologically evaluated for their potential inhibitory outcome for both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). These compounds exhibited high activity against both the enzymes AChE as well as BuChE. Of the synthesized compounds, the most potent isoalloxazine derivatives (7m and 7q) showed IC50 values of 4.72 mu M and 5.22 mu M respectively against AChE; and, 6.98 mu M and 5.29 mu M respectively against BuChE. These two compounds were further evaluated for their anti-aggregatory activity for beta-amyloid (A beta) in presence and absence of AChE by performing Thioflavin-T (ThT) assay and Congo red (CR) binding assay. In order to evaluate cytotoxic profile of these two potential compounds, cell viability assay of SH-SY5Y human neuroblastoma cells was performed. Further, to understand the binding behavior of these two compounds with AChE and BuChE enzymes, docking studies have been reported. (C) 2015 Elsevier Inc. All rights reserved.
  • Indoloquinoxaline derivatives as promising multi-functional anti-Alzheimer agents
    作者:Ashish M. Kanhed、Dushyant V. Patel、Nirav R. Patel、Anshuman Sinha、Priyanka S. Thakor、Kishan B. Patel、Navnit K. Prajapati、Kirti V. Patel、Mange Ram Yadav
    DOI:10.1080/07391102.2020.1840441
    日期:2022.4.13
    Abstract To confront a disease like Alzheimers disease having complex pathogenesis, development of multitarget-directed ligands has emerged as a promising drug discovery approach. In our endeavor towards the development of multitarget-directed ligands for Alzheimers disease, a series of indoloquinoxaline derivatives were designed and synthesized. In vitro cholinesterase inhibition studies revealed
    摘要 为了对抗阿尔茨海默病等具有复杂发病机制的疾病,多靶点定向配体的开发已成为一种有前途的药物发现方法。在我们致力于开发针对阿尔茨海默病的多靶点定向配体的过程中,设计并合成了一系列吲哚喹喔啉衍生物。体外胆碱酯酶抑制研究表明,所有合成的化合物都表现出中等至良好的胆碱酯酶抑制活性。6-(6-(Piperidin-1-yl)hexyl)-6 H -indolo[2,3- b ]quinoxaline 9f被确定为最有效和选择性的 BuChE 抑制剂 (IC 50= 0.96 µM,选择性指数 = 0.17),与商业批准的参考药物多奈哌齐 (IC 50 = 1.87 µM)相比,BuChE 抑制活性高出 2 倍。此外,化合物9f还具有自诱导 Aβ 1-42聚集抑制活性(在 50 μM 浓度下抑制 51.24%)。该系列的一些化合物也显示出适度的抗氧化活性。为了解化合物9f的推定结合模式,进行了分子
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐